Yong He
Clinical trials sponsored by Yong He, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Balloon treatment could stop hidden heart plaques from causing attacks Results expected Jun 2027 (estimated)
- Radioactive antibody aims to light up hidden solid tumors Results expected Sep 2027 (estimated)
-
New PET tracer targets ACP3 to spot prostate cancer
Diagnosis Not yet recruitingResearchers are testing a new PET imaging agent called [68Ga]Ga-OncoACP3 that targets a protein called ACP3, which is found in prostate cancer cells. The study enrolls 50 men with suspected or confirmed high-risk prostate cancer, or suspected recurrence after treatment. Each part…
Phase 2 • Sponsor: Yong He • Aim: Diagnosis
Last updated Sep 21, 2026 16:00 UTC
-
Radioactive antibody aims to light up hidden solid tumors
Diagnosis Not yet recruitingResearchers are testing a new imaging agent called 111In-TJD-31 that targets placental alkaline phosphatase (ALPP), a protein found on many solid tumor cells but rarely in healthy adult tissue. The study enrolls 8 participants: 2 healthy volunteers who give blood samples and 6 pa…
Phase 1 • Sponsor: Yong He • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC